Perforomist

Concomitant use of Perforomist & tiotropium -- significant improvements -- COPD

Napa, CA (May 20, 2008) Data presented today at the International Conference of the American Thoracic Society (ATS) demonstrate that concomitant therapy with Perforomist Inhalation Solution (formoterol fumarate inhalation solution; FFIS), delivered by nebulization, and Spiriva (tiotropium; TIO) i...

Perforomist Inhalation Solution data to be presented today at American Thoracic Society conference

...ata from two presentations highlighting the use of perforomist (formoterol fumarate) Inhalation Solution in moder...cic Society in San Diego. In one analysis, use of perforomist Inhalation Solution, when added to maintenance tio...tient satisfaction increased in those treated with perforomist Inhalation Solution twice daily compared with ipra...

Perforomist(R) Inhalation Solution Data in Patients With Moderate to Severe COPD to Be Presented at the International Conference of the American Thoracic Society

...cic Society in San Diego. In one analysis, use of perforomist Inhalation Solution, when added to maintenance tio...tient satisfaction increased in those treated with perforomist Inhalation Solution twice daily compared with ipra... metered-dose inhaler (MDI) four times daily. perforomist Inhalation Solution was approved in 2007 by the U....

Perforomist Inhalation Solution data to be presented at American Thoracic Society conference

...ata from two presentations highlighting the use of perforomist (formoterol fumarate) Inhalation Solution will be ...9, 2009 in San Diego. In one analysis, use of perforomist Inhalation Solution, when added to maintenance tio...tient satisfaction increased in those treated with perforomist Inhalation Solution twice daily compared with ipra...

Dey, L.P. Highlights Perforomist(R) Inhalation Solution Data to Be Presented at the International Conference of the American Thoracic Society

... 2009 in San Diego. In one analysis, use of perforomist Inhalation Solution, when added to maintenance tio...tient satisfaction increased in those treated with perforomist Inhalation Solution twice daily compared with ipra...vering medicine directly into the lungs. With perforomist Inhalation Solution, nebulization may become a mor...

Concomitant treatment with nebulized formoterol fumarate & tio-significant improvements -- COPD

...fficacy and safety of the concomitant treatment of perforomist nebulized formoterol fumarate (a long-acting β...thor and principal investigator of the study. When perforomist Solutions rapid onset of action is combined with t...ta Results from the Phase III pivotal trial of perforomist (formoterol fumarate) Inhalation Solution, the fir...

Clinical trial data: Safety/efficacy of concomitant formoterol fumarate/tiotropium treating COPD

...ilable version of nebulized formoterol fumarate is perforomist Inhalation Solution, which is indicated for long-t...ion and has twenty years of worldwide experience. perforomist Inhalation Solution is the first and only FDA-appr...ion over use of tiotropium alone. For physicians, perforomist Inhalation Solution and commonly prescribed long-a...

Perforomist in Medical Technology

PARI LC Plus and PRONEB Ultra Used in Two Perforomist Studies on Improving COPD Therapies

MIDLOTHIAN, Va., June 30 /PRNewswire/ -- In two recent COPD studies sponsored by DEY LP, PARI's LC Plus nebulizer and PRONEB compressors (Ultra and Ultra II) were used to show that nebulized formoterol fumarate (Perforomist, DEY LP, Mylan Inc.) improves pulmonary function. "We are pleased th...

Clinical Trial Data for Perforomist Inhalation Solution to be Presented at ATS on May 20, 2007

-- Data from Phase III pivotal trial demonstrate safety and efficacy of first FDA-approved nebulized formoterol fumarate for patients with moderate to severe COPD -- NAPA, Calif., May 16, 2007 /PRNewswire/ -- Dey, L.P. announced that two clinical data presentations will be given at the Internation...

Clinical Trial Data for Perforomist (Formoterol Fumarate) Inhalation Solution Presented at International ATS Conference

-- New product recently approved by FDA for long-term maintenance treatment of COPD bronchoconstriction; data demonstrate first nebulized formoterol fumarate provides improved lung function comparable to dry powder formoterol, enhanced patient quality of life, and positive safety profile -- NAPA, ...

Clinical Trial Data for Perforomist (Formoterol Fumarate) Inhalation Solution Presented at International ATS Conference

-- New product recently approved by FDA for long-term maintenance treatment of COPD bronchoconstriction; data demonstrate first nebulized formoterol fumarate provides improved lung function comparable to dry powder formoterol, enhanced patient quality of life, and positive safety profile -- NAPA...

Concomitant Use of Nebulized Formoterol Fumarate and Tiotropium Provides Significant Improvement in Dyspnea, COPD Symptoms and Rescue Medication Use over Tiotropium Alone

... careful investigation into the clinical benefits of concomitant therapy of perforomist and tiotropium. At DEY, we are committed to developing effective new treatments for serious and complex diseases, and with perforomist are proud to provide physicians and patients a twice-daily COPD maintenance...

Clinical Trial Data on the Safety and Efficacy of Concomitant Formoterol Fumarate/ Tiotropium Treatment for COPD

...neb.com, http://www.curosurfusa.com, http://www.cyanokit.com, http://www.duoneb.com, http://www.epipen.com and http://www.perforomist.com . perforomist is a trademark of Dey, L.P. About Mylan Mylan Inc. is one of the world's leading quality generic and specialty pharmaceutical companies. The Company...

Data from Three Clinical Trials for Perforomist(TM) Inhalation Solution to be Presented at CHEST 2007 on October 24, 2007

...www.duoneb.com, http://www.epipen.com and http://www.perforomist.com . perforomist is a trademark of Dey, L.P. About Mylan Mylan Inc. is one of the world's ...ents that constitute "forward-looking statements," including with regard to perforomist and research results. These statements are made pursuant to the safe harbor...

Perforomist in Biological Technology

PARI Respiratory's LC PLUS & PRONEB Ultra Deliver Dey, L.P.'s New COPD Therapy; Perforomist Launched Yesterday

MIDLOTHIAN, Va., Oct. 9 /PRNewswire/ -- PARI Respiratory Equipment's breath-enhanced nebulizer, the PARI LC PLUS, and PRONEB Ultra compressor deliver Dey, L.P.'s new COPD medication, Perforomist Inhalation Solution, that launched nationwide yesterday. Dey, L.P. is a subsidiary of Mylan Inc. (N...

Mylan Reports Adjusted Diluted EPS of $0.32 for the Quarter Ended June 30, 2009

...llion, compared to $183.0 million for the six months ended June 30, 2008. EpiPen was the primary driver of the increase in revenues. Higher sales of perforomist were offset by lower sales of DuoNeb(R), which continues to experience the unfavorable impact of generic competition, which first entered the market i...

Mylan Inc. Subsidiary, Dey, L.P., Announces that Perforomist(TM) (Formoterol Fumarate) Inhalation Solution is Now Available for Maintenance Treatment of COPD

...neb.com, http://www.curosurfusa.com, http://www.cyanokit.com, http://www.duoneb.com, http://www.epipen.com and http://www.perforomist.com . perforomist is a trademark of Dey, L.P. About Mylan Mylan Inc. is one of the world's leading quality generic and specialty pharmaceutical companies. The Company...